# Long-Term Follow-up Safety After DDS Implantation With/Without CDNF Infusions

> **NCT04228653** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Renishaw** · enrollment: 15 (actual)

## Conditions studied

- Parkinson Disease
- Movement Disorders
- Neuro-Degenerative Disease
- Nervous System Diseases
- Brain Diseases

## Interventions

- **DEVICE:** Renishaw Drug Delivery System

## Key facts

- **NCT ID:** NCT04228653
- **Lead sponsor:** Renishaw
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-03-20
- **Primary completion:** 2022-09-20
- **Final completion:** 2023-03-20
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2021-03-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04228653

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04228653, "Long-Term Follow-up Safety After DDS Implantation With/Without CDNF Infusions". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04228653. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*